Clinical Trial: Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)

U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07469293) titled 'Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)' on Feb. 09.

Brief Summary: DATE-MeVO is an investigator-initiated, multicenter, prospective, randomized controlled, open-label, blinded endpoint (PROBE) clinical trial aiming at evaluating the efficacy and safety of tenecteplase combined with standard medications in acute ischemic stroke patients with medium vessel occlusion stroke within 24 hours of onset.

Study Start Date: Feb. 15

Study Type: INTERVENTIONAL

Condition: Acute Ischemic Stroke

Intervention: PROCEDURE: Intra-arterial thrombolysis...